European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted
about
Biomarker profiling by nuclear magnetic resonance spectroscopy for the prediction of all-cause mortality: an observational study of 17,345 personsESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD - SummaryExercise-based cardiac rehabilitation for coronary heart diseaseRisk scoring for the primary prevention of cardiovascular diseaseVitamin C for treating atrial fibrillationEffects of total fat intake on body weightMobile phone text messaging to improve adherence to cardiovascular disease secondary prevention interventionsInterventions to improve the appropriate use of polypharmacy for older peoplePromoting patient uptake and adherence in cardiac rehabilitationFixed-dose combination therapy for the prevention of cardiovascular diseaseBlood pressure targets for the treatment of patients with hypertension and cardiovascular diseasePlatelet glycoprotein IIb/IIIa blockers during percutaneous coronary intervention and as the initial medical treatment of non-ST segment elevation acute coronary syndromesPlatelet glycoprotein IIb/IIIa blockers during percutaneous coronary intervention and as the initial medical treatment of non-ST segment elevation acute coronary syndromesVitamin C for treating atrial fibrillationCardiovascular risk assessment in rheumatoid arthritis - controversies and the new approachPrevalence of familial hypercholesterolemia: a meta-analysis of six large, observational, population-based studies in PolandRisk assessment in the prevention of cardiovascular disease in low-resource settingsNutrition and Cardiovascular Disease: Finding the Perfect Recipe for Cardiovascular Health2015 Korean Guidelines for the Management of Dyslipidemia: Executive Summary (English Translation)PCSK9 inhibition in the management of hyperlipidemia: focus on evolocumabCoronary artery calcification in clinical practice: what we have learned and why should it routinely be reported on chest CT?Lifestyle changes for the treatment of nonalcoholic fatty liver disease: a review of observational studies and intervention trialsCardiovascular risk stratification in familial hypercholesterolaemiaFasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points-a joint consensus statement from the European Atherosclerosis Society and EuropeanEuropean LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemiaAssessment and impact of diastolic function by echocardiography in elderly patientsAspirin for primary prevention of cardiovascular diseaseCardiovascular Disease Burden: Evolving Knowledge of Risk Factors in Myocardial Infarction and Stroke through Population-Based Research and Perspectives in Global PreventionImpact of treatment with rosuvastatin and atorvastatin on cardiovascular outcomes: evidence from the Archimedes-simulated clinical trialsQuality markers in cardiology: measures of outcomes and clinical practice--a perspective of the Spanish Society of Cardiology and of Thoracic and Cardiovascular SurgeryUnderstanding and treating hypertension in diabetic populationsOptimal Use of Plant Stanol Ester in the Management of HypercholesterolemiaNovel Methods for Pulse Wave Velocity MeasurementPrevalence, Treatment, and Control of Hypercholesterolemia in High Cardiovascular Risk Patients: Evidences from a Systematic Literature Review in SpainPhytosterols, Phytostanols, and Lipoprotein MetabolismStatins for primary cardiovascular prevention in the elderlyThe effect of statins on average survival in randomised trials, an analysis of end point postponementCardiovascular Imaging for the Primary Prevention of Atherosclerotic Cardiovascular Disease EventsManaging lifestyle change to reduce coronary risk: a synthesis of qualitative research on peoples' experiencesRole of exercise in the prevention of cardiovascular disease: results, mechanisms, and new perspectives
P2860
Q21562282-6977DB9D-71F8-4E34-9810-105E4FB62A20Q22241786-CBFBBBAC-6330-42B6-9BB7-B59A76902D42Q24186576-2778F0F0-847D-49D4-ADB3-D37FB484F1E3Q24186884-E95CAFE4-736F-4283-A67C-9BC3EAE6644EQ24186942-75FCF44E-A051-49DC-B7FF-B9EA0A75A814Q24187985-57098E49-50DB-4795-9B00-7C69BD8A01FAQ24188063-3C741AC7-19B7-4418-AD5A-AF28ED211EB7Q24193171-FFF02FB2-7AF1-48D3-A7D9-27A095D39EF2Q24193773-78B393C9-771D-49C7-A24A-83E5BA73ECB0Q24195065-0063D98C-E0B3-4250-BFE5-F40DF5E6B3DEQ24201957-522F7339-8382-4D9C-A787-970CCE87F382Q24202522-AE1F4E73-6A90-469E-91D8-06C4ABC6D38DQ24202999-7E9CC7DE-2D10-4E23-AE6E-66F6431D72D0Q26471829-7DC77E57-47AE-40F9-9300-3AAA405F2AF9Q26738461-80809624-4301-4177-9D8E-87F7E5357A3BQ26740377-479F2B1B-5E64-4647-9B7D-CEEF485615ECQ26744435-D910AB86-C47F-4F20-992C-B60CDF04B164Q26744466-DABDB04A-FD1C-4153-A0C6-279EEABB718AQ26747559-5D3ECA60-7547-403E-BC3A-7CCA00719652Q26747776-0B714F4C-6F36-4A78-81BF-BEE260809ACAQ26747779-2237A2ED-9E32-460D-A2F5-438AFA8DE0D9Q26748608-805E8B73-CADC-422B-99A9-980BC2675A96Q26749104-1B8DCAA6-CBD5-448F-9B0C-AFC9AD12FAE4Q26749306-61562A6F-CBF2-4799-88FF-A35974229E5BQ26749324-675C784B-EF55-4147-AB52-BEDA41F1CECDQ26751096-89BF7281-54EF-4880-BDA5-F413570C25E0Q26774150-4D259B0C-8562-4E52-ADE6-48A03D5256FCQ26776110-D4CC5E01-0E15-458D-8F92-39A637B75B1FQ26776293-AF15AFC2-FA00-4018-ACE4-39FAB94A15DFQ26778567-796EFFA6-85C4-4192-8B81-717CF1662554Q26778662-71B84E41-B351-42CF-826F-ED87661AE896Q26778700-D8CFF772-18B4-4A66-802F-096D04E34B38Q26779339-B50C5CFD-5829-4B4E-ACB5-EC29F18EC4EDQ26779403-674CD543-EEBA-44CC-AC16-5115E50EB64BQ26782231-CE6D346A-CD0B-47D4-AE3A-C0F044D1CDA5Q26783401-30E65A92-9697-4917-8361-957160A5F16DQ26786733-E4C18A17-1CBE-4A7F-A2C5-FC5C8524FC35Q26795419-911543C1-8C75-41E6-8CCF-0D979DD41A6EQ26822696-1C80A29E-CADB-4A34-AB0C-C21CF70004C5Q26824706-4BCB0C04-07BB-40DA-B87F-07FCF5DAA177
P2860
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
European Guidelines on cardiov ...... Clinical Practice (constituted
@en
European Guidelines on cardiovascular disease prevention in clinical practice
@nl
type
label
European Guidelines on cardiov ...... Clinical Practice (constituted
@en
European Guidelines on cardiovascular disease prevention in clinical practice
@nl
prefLabel
European Guidelines on cardiov ...... Clinical Practice (constituted
@en
European Guidelines on cardiovascular disease prevention in clinical practice
@nl
P2093
P50
P356
P1476
European Guidelines on cardiov ...... Clinical Practice (constituted
@en
P2093
Christi Deaton
Christian Albus
David Wood
ESC Committee for Practice Guidelines (CPG)
European Association for Cardiovascular Prevention & Rehabilitation (EACPR)
Giuseppe Germano
Gudrun Boysen
Helmut Gohlke
Ian Graham
P304
P356
10.1093/EURHEARTJ/EHS092
P50
P577
2012-05-03T00:00:00Z